Literature DB >> 8142268

Verapamil: what is the mechanism of its anticarcinogenic activity?

G Brambilla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8142268      PMCID： PMC1968799          DOI： 10.1038/bjc.1994.150

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  4 in total

Review 1.  Pharmacology of drugs that alter multidrug resistance in cancer.

Authors:  J M Ford; W N Hait
Journal:  Pharmacol Rev       Date:  1990-09       Impact factor: 25.468

2.  Induction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogens.

Authors:  H Tsuda; G Lee; E Farber
Journal:  Cancer Res       Date:  1980-04       Impact factor: 12.701

3.  Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics.

Authors:  R K Burt; S S Thorgeirsson
Journal:  J Natl Cancer Inst       Date:  1988-11-02       Impact factor: 13.506

4.  Inhibition by verapamil of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.

Authors:  H Uehara; A Nakaizumi; M Baba; H Iishi; M Tatsuta
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640
  4 in total
  1 in total

1.  A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin.

Authors:  S A Glynn; P Gammell; M Heenan; R O'Connor; Y Liang; J Keenan; M Clynes
Journal:  Br J Cancer       Date:  2004-11-15       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.